Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical enzyme therapy for skin diseases?

Kenneth H Kraemer1, John J DiGiovanna

  • 1Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Bldg. 37, Room 3E24, Bethesda, MD 20892, USA. kraemerk@nih.gov

Journal of the American Academy of Dermatology
|February 28, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA Lariat-Debranching Enzyme (DBR1) Variations in Sabinas Brittle Hair Syndrome Form of Trichothiodystrophy: A Trichothiodystrophy-Causing Gene.

The Journal of investigative dermatology·2025
Same author

Co-infection of HSV-1 amplicons containing the <i>XPC</i> gene and a human artificial chromosome vector into primary XPC deficient fibroblast cells.

Biochemistry and biophysics reports·2024
Same author

Different germline variants in the XPA gene are associated with severe, intermediate, or mild neurodegeneration in xeroderma pigmentosum patients.

PLoS genetics·2024
Same author

Personalized sun protection equation: Dermatology + Psychology = XPAND.

The British journal of dermatology·2024
Same author

Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers.

Frontiers in oncology·2023
Same author

A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.

The Journal of clinical investigation·2023